| Bone Marrow Conditioning Regimen |
22.3% |
| Prophylaxis Against Graft Versus Host Disease |
18.1% |
| Product Used For Unknown Indication |
8.5% |
| Stem Cell Transplant |
5.8% |
| Acute Myeloid Leukemia |
5.4% |
| Mds |
5.4% |
| Ovarian Cancer |
4.2% |
| Prophylaxis |
4.2% |
| Immunosuppression |
3.8% |
| Combined Immunodeficiency |
3.5% |
| Autoimmune Disorder |
2.3% |
| Chronic Lymphocytic Leukaemia |
2.3% |
| Cytomegalovirus Infection Reactivation |
2.3% |
| Infection Prophylaxis |
2.3% |
| Prophylaxis Against Transplant Rejection |
2.3% |
| Immunodeficiency Congenital |
1.5% |
| Off Label Use |
1.5% |
| Pneumocystis Jiroveci Infection |
1.5% |
| Prostate Cancer |
1.5% |
| Antifungal Prophylaxis |
1.2% |
